Current solutions are not working. According to the Substance Abuse and Mental Health Services Administration’s (SAMSHA’s) National Survey on Drug Use and Health:

  • 23.5 million persons needed treatment for an illicit drug or alcohol abuse problem in 2009.
  • From 2000-2010, the incidence of drug use in a group being treated for some form of mental illness was more than double that of the group that was not currently treated for mental illness – 25.8 percent vs. 12.1 percent.
  • Drug abuse results in behavioral and biological health issues that affect individuals, families, and communities. Economic estimates indicate consequences from drug abuse approach 20% of our federal budget. (source NIDA)

The Problem

  • Ordering medication compliance testing can be time consuming for healthcare providers and is generally guided by treatment and medication lists; in addition, test ordering may overlook illicit medications and drugs not identified by patients.

Our Solution

  • Compliance programs should be simple and actionable
  • ADVISR identifies patients who should be tested – which lowers cost by focusing on those patients who are non-compliant.
  • ADVISR simplifies test-ordering for providers, ensures only medically necessary testing is performed, and maximizes value of clinical data for outcome driven patient treatment.